JPRN-UMIN000023246
Unknown
未知
Intraoperative Photodynamic Diagnosis study by fluorescent labeling with 5-aminolevulinic acid in Endocrine Surgery - IPDES
Endocrine surgery, Nippon Medical School0 sites60 target enrollmentAugust 1, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Thyroid, parathyroid and adrenal diseases
- Sponsor
- Endocrine surgery, Nippon Medical School
- Enrollment
- 60
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who are contraindication to aminolevulinic acid. Patients who have cardiovascular disease, liver dysfunction or kidney disease. Patients who are under 20 years old, expectant or nursing mothers are excluded. Patients who take medication or food associated with the risk for the onset of photo\-hypersensitivity with 5\-ALA.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Feasibility study of in vivo photodynamic diagnosis using 5ALA for head and neck or gastrointestinal cancerHead and neck or Gastrointestinal cancerJPRN-UMIN000013791ational Cancer Center Hospital East16
Completed
Not Applicable
Photodynamic diagnosis involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in surveillance of non muscle invasive bladder cancerbladder cancerJPRN-UMIN000038906ara Medical University162
Completed
Phase 1
The safety and efficacy of photodynamic diagnosis with SPP-006 at staging laparoscopy for advanced gastric cancer. Prospective multi-center trial.JPRN-jRCT2091220225Osaka University Hospital30
Completed
Phase 3
The efficacy and safety of photodynamic diagnosis with SPP-005 at staging laparoscopy for advanced gastric cancer. Prospective multi-center trial.large type 3 or type 4 gastric cancerJPRN-jRCT2091220309Osaka University Hospital105
Recruiting
Phase 3
Photodynamic diagnosis of non muscle invasive bladder cancer using fluorescence cystoscopy with oral administration of 5-aminolevulinic acid(5-ALA)on muscle invasive bladder cancerJPRN-UMIN000010798Department of urology and Andrology, Kansai Medical University30